Project Details
Description
A Phase III, Randomized, Double-Blind, Placebo-controlled Study at Assess the Efficacy and Safety of 10mg ZD4054 in Combination with Docataxel in comparison with Docetaxel in Patients with Metastatic Hormone- resistant Prostate Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/09 → 12/31/11 |
Funding
- ASTRAZENECA
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.